Nintedanib esylateMeSH concept

OFEV (nintedanib) - Risk of Drug-Induced Liver Injury and the Need for Regular Monitoring of Liver Function
http://canadiensensante.gc.ca/recall-alert-rappel-avis/hc-sc/2018/65670a-fra.php
2018
false
false
false
Canada
French
English
pharmacovigilance note
administration, oral
nintedanib
nintedanib
drug monitoring
continuity of patient care
Chemical and Drug Induced Liver Injury
Chemical and Drug Induced Liver Injury
liver function tests
transaminases
bilirubin
idiopathic pulmonary fibrosis
nintedanib esylate
indoles

---
http://www.has-sante.fr/portail/jcms/c_2038122/fr/ofev
http://www.has-sante.fr/portail/jcms/c_2038122/fr/ofev-nintedanib-inhibiteur-des-tyrosines-kinases
2015
false
false
false
France
French
evaluation of the transparency committee
administration, oral
treatment outcome
insurance, health, reimbursement
nintedanib esylate
nintedanib esylate
idiopathic pulmonary fibrosis
adult
orphan drug production
enzyme inhibitors
enzyme inhibitors
protein-tyrosine kinases
guidelines for drug use
nintedanib
Tyrosine Kinase Inhibitors
nintedanib
nintedanib
indoles
indoles

---
http://www.has-sante.fr/portail/jcms/c_2048057/fr/vargatef
http://www.has-sante.fr/portail/jcms/c_2048057/fr/vargatef-nintedanib-inhibiteur-de-tyrosine-kinase
2015
false
false
false
France
French
evaluation of the transparency committee
treatment outcome
administration, oral
nintedanib
nintedanib
nintedanib esylate
nintedanib esylate
antineoplastic combined chemotherapy protocols
antineoplastic agents
antineoplastic agents
adenocarcinoma
carcinoma, non-small-cell lung
adult
neoplasm metastasis
Locally Advanced Malignant Neoplasm
neoplasm recurrence, local
insurance, health, reimbursement
enzyme inhibitors
enzyme inhibitors
receptors, fibroblast growth factor
receptors, platelet-derived growth factor
receptors, vascular endothelial growth factor
nintedanib
guidelines for drug use
Tyrosine Kinase Inhibitors
indoles
indoles

---